Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
ACT4RHD is an Open-label, Randomised, Adaptive Platform Trial to Evaluate Novel and Repurposed Clinical Interventions for Patients With Acute Rheumatic Fever and Carditis. ACT4RHD Seeks to Determine Whether These Interventions Reduce RHD Severity at 6 Months.Bacterial Infections and Mycoses, Infections, Skin and Connective Tissue Diseases, arthritic joint disease, arthropathy, bacterial infectious disease, cardiovascular disorder, connective tissue disorder, gram-positive bacterial infections, heart disorder, musculoskeletal system disorder, rheumatic disorder, rheumatic fever, rheumatic heart disease, streptococcal infectionNot yet recruitingPhase 32026-10-07NCT07830108

3 results · Page 1 of 1

Swipe the table sideways for more columns.

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
KidzFirst HospitalAucklandNew Zealand1
Royal HospitalDarwinAustralia1
Starship Child Health, Te Toka Tumai, AucklandAucklandNew Zealand1